Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121791012 | 12179101 | 2 | F | 20160920 | 20160315 | 20160926 | EXP | PHJP2016JP005333 | NOVARTIS | 58.00 | YR | F | Y | 0.00000 | 20160926 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121791012 | 12179101 | 1 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 200 MG, BID | 16608 | 200 | MG | TABLET | BID | ||||||
| 121791012 | 12179101 | 2 | SS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 400 MG, BID | 16608 | 400 | MG | TABLET | BID | ||||||
| 121791012 | 12179101 | 3 | SS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 200 MG, BID | 16608 | 200 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121791012 | 12179101 | 1 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121791012 | 12179101 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121791012 | 12179101 | Dizziness | |
| 121791012 | 12179101 | Herpes zoster | |
| 121791012 | 12179101 | Incorrect dose administered |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |